The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,733.50
Bid: 1,732.50
Ask: 1,733.00
Change: 0.00 (0.00%)
Spread: 0.50 (0.029%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1,733.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

MARKET COMMENT: UK Stocks Close Mixed Ahead Of Fed Minutes

Tue, 19th Nov 2013 17:25

LONDON (Alliance News) - UK stocks closed mixed Tuesday, with small-caps outperforming their larger peers, as investors stayed cautious and continued to look for signs of when the US Federal Reserve will start slowing its asset purchase program.

Departing Federal Reserve Chairman Ben Bernanke gives a speech Wednesday and the central bank's policy-setting committee will also release the minutes of its last meeting.

Ahead of these events, "investors seem to care less about the fundamentals of the markets and the companies that they invest in, and more about the direction of policy of the central banks, and in particular the Federal Reserve," said Michael Hewson, chief market analyst at CMC Markets.

Top Fed officials Charles Plosser and William Dudley Monday pointed to improvement in the US economy, increasing investor anxiety ahead of Bernanke speech.

"Plosser, who will be a voting member of the Fed committee in 2014, made his stance very clear, proposing a defined end to the asset purchase programme and warning that a continuation of the current bond buying game undermines the Fed's credibility," said Toby Morris, senior sales trader at CMC Markets.

The tapering of the Fed's USD85 billion-a-month stimulus programme is deemed negative for equities because the flow of cheap money has been lifting the economy and companies.

Separately, speaking at the Reuters Global Investment Outlook Summit, US billionaire investor Carl Icahn said he is "very cautious" on the stock market and that a "big drop" is likely as companies are fueled more by low borrowing costs than management's efforts to boost results.

The FTSE 100 closed down 0.4% at 6,698.01, while the FTSE 250 closed down 0.2% at 15,265.6. Similar negative sentiment was shared in European indices; with the French CAC closing down 1.1% and the German DAX closing down 0.4%.

The small-cap AIM All-Share index, however, closed up 0.1% at 810.77, proving to be less sensitive to the monetary policy debate, buoyed by a series of strong reports from its constituents.

At the close of the UK equities market, the S&P 500, the DJIA, and the Nasdaq were all trading close to flat, having experienced a late selloff Monday.

The Organization for Economic Co-operation and Development downgraded its global growth projections Tuesday, citing worsening outlook for some emerging economies. In the latest semi-annual Economic Outlook, the organization underscored a range of downside risks to the recovery and cautioned that the path is set to be turbulent.

The world economy will grow 2.7% this year, the OECD said, down from the 3.1% projected in May. Growth in 2014 is expected to pick up to 3.6%, which was a downward revision from 4.0%. The OECD expects growth to accelerate to 3.9% in 2015.

There was good news for the UK, however, where the projection for growth in 2014 was revised up to 2.4% from 1.5%, the largest upgrade to any country in the OECD. The projection for this year was revised up to 1.4%, from 0.8%.

German investor confidence hit a four-year high in November, a key survey released Tuesday showed, adding to hopes about the outlook for Europe's biggest economy. The closely watched indicator gauging the mood among analysts and institutional investors climbed to a more-than-forecast 54.6 points in November, from 52.8 last month, the Mannheim-based ZEW institute said, ahead of expectations of a rise to 54.0.

"Economic expectations for Germany have been hovering at a high level for months," ZEW President Clemens Fuest said. "The slightly improved economic outlook for the Eurozone might have contributed to this development."

However, analysts were less upbeat and pointed out that the ZEW index was not the best indicator to track the economic activity in the biggest Eurozone economy. They also drew attention to the sustained decline in the current conditions index. The current conditions index for Germany dropped for a second successive month, down to 28.7 from 29.7, in contrast to expectations of an improvement to 31.

In a busy day of corporate reporting, easyJet, closing up 6.6% at 1,339.40 pence, was the biggest gainer in the FTSE 100. The blue-chip airline reported that pretax profit for the year to September 30 rose by 51% to GBP478 million, up from GBP317 million reported last year, and proposed a 56% increase in its total dividend to 33.5 pence as well as a special dividend of 44.1 pence.

Blue-chip TUI Travel, closing up 0.5% at 388.931p, and FTSE 250-listed Thomas Cook Group, closing up 4.6% at 147.008p were also big winners. The travel agencies sold their interests in UK air-traffic controller NATS Holdings for GBP38 million each.

Afren, closing up 9% at 162.3052p, was another leading riser on the FTSE 250. Afren and its AIM-listed partner Lekoil reported that drilling results at the OPL310 site offshore Nigeria are nearly four times higher than previous expectations. Lekoil closed up 21% at 60.05p.

GlaxoSmithKline, closing up 1% at 1,628.90p, was amongst the leading FTSE 100 gainers after it said it will sell about a third of its 19% stake in Aspen Pharmacare Holdings Ltd. as it cashes in on some of Aspen's value growth in recent years. "GSK has a long and successful partnership with Aspen - and our investment in the company has grown in value significantly over time. Having assessed this investment we have now decided to realise some of this value without altering the basis of the partnership," Glaxo Chief Strategy Officer David Redfern said in a statement. Aspen shares are up 70.5% in the last 52 weeks alone, having risen for several years. Glaxo closed up 1% at 1,629.00p.

There was more bad news for G4S after the UK government rejected an offer to refund it GBP24.1 million for overcharging on a contract to tag criminals, after the outsourcing company said it own internal review by a law firm had found there was overcharging on the contract but its employees didn't break any laws.

The National Audit Office, which has just produced a report for parliament setting out events around the contract, said the Ministry had not currently agreed to any refund offers. G4S shares closed up 0.9% Tuesday.

In a much lighter corporate calendar Wednesday, FTSE 250-listed HICL Infrastructure Company and Utilico Emerging Markets, amongst others, release interim results.

In Wednesday's data calendar, outgoing Federal Reserve Chairman Ben Bernanke speaks overnight ahead of the much-anticipated release of the FOMC minutes at 1900 GMT. The Bank of England is set to release its minutes from its last rate-setting meeting at 0930 GMT. In the US, mortgage application information is expected at 100 GMT, before CPI and RPI figures are released at 1330 GMT.

By James Kemp; jameskemp@alliancenews.com; @jamespkemp

Copyright 2013 Alliance News Limited. All Rights Reserved.

More News
2 May 2024 19:57

GSK knew about Zantac cancer risk, attorneys tell jury in first trial

May 2 (Reuters) - U.S. attorneys for a woman who claims her colon cancer was caused by the now discontinued heartburn drug Zantac on Thursday told a jury in Chicago that pharmaceutical companies GSK and Boehringer Ingelheim knew the product could cause cancer if it was not handled properly but failed to warn the public.

Read more
2 May 2024 09:48

LONDON BROKER RATINGS: Deutsche Bank likes TP ICAP but says sell CMC

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

Read more
1 May 2024 19:39

Bird flu testing shows more dairy products are safe, US FDA says

CHICAGO, May 1 (Reuters) - Preliminary results of tests on additional dairy products show that pasteurization inactivates the bird flu virus, the U.S. Food and Drug Administration said on Wednesday.

Read more
1 May 2024 17:31

UK's FTSE 100 slips ahead of Fed outcome, energy stocks weigh

FTSE 100 down 0.3%, FTSE 250 off 0.2%

*

Read more
1 May 2024 16:56

LONDON MARKET CLOSE: FTSE 100 down ahead of US interest rate decision

(Alliance News) - Stock prices in London closed mostly in the red on Wednesday, as investors eye the latest interest rate decision from the US Federal Reserve this evening.

Read more
1 May 2024 16:42

London close: Stocks fall ahead of US Fed decision

(Sharecast News) - London markets closed lower on Wednesday, as investors digested the latest UK manufacturing data and anticipated an impending policy announcement from the US Federal Reserve.

Read more
1 May 2024 11:55

LONDON MARKET MIDDAY: FTSE 100 treads water as Fed takes centre-stage

(Alliance News) - London's FTSE 100 traded off session highs heading into Wednesday afternoon, as some pre-Federal Reserve decision nerves kicked in.

Read more
1 May 2024 10:54

GSK raises profit outlook on strong vaccine, HIV drug sales

FY profit forecast raised to 8-10%

*

Read more
1 May 2024 08:57

LONDON MARKET OPEN: FTSE 100 shakes off New York slump before Fed

(Alliance News) - Stock prices in London opened mixed on Wednesday, with the FTSE 100 brushing off some pre-Federal Reserve decision trepidation to record an early rise, while the dollar climbed on the expectation that Jerome Powell will sound hawkish in his press conference later.

Read more
1 May 2024 08:50

TOP NEWS: GSK expects momentum to continue after strong first quarter

(Alliance News) - GSK PLC on Wednesday raised its annual earnings forecast, and said it expects sales growth at the top-end of guidance, after a "strong" start to the year.

Read more
1 May 2024 07:46

LONDON BRIEFING: GSK ups outlook; Next first-quarter beats forecast

(Alliance News) - Equities in London are called to open flat on Wednesday, ahead of the latest Federal Reserve interest rate decision, while a host of financial markets in mainland Europe and beyond are closed for public holidays.

Read more
1 May 2024 07:36

GSK lifts annual guidance on strong virus treatment sales

(Sharecast News) - UK pharmaceutical giant GSK lifted annual profits guidance on Wednesday, as it pinned its hopes on demand for its respiratory virus and shingles treatments.

Read more
30 Apr 2024 23:46

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 22:39

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 13:51

Sensodyne maker Haleon to shut UK factory with loss of 435 jobs

(Alliance News) - More than 400 jobs are to be axed at Sensodyne toothpaste and Advil painkillers firm Haleon PLC as the group revealed plans to shut its only manufacturing site in the UK.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.